These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25302371)

  • 1. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
    Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
    Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.
    Vereecke L; Beyaert R; van Loo G
    Biochem Soc Trans; 2011 Aug; 39(4):1086-91. PubMed ID: 21787353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
    Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
    PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus.
    Musone SL; Taylor KE; Lu TT; Nititham J; Ferreira RC; Ortmann W; Shifrin N; Petri MA; Kamboh MI; Manzi S; Seldin MF; Gregersen PK; Behrens TW; Ma A; Kwok PY; Criswell LA
    Nat Genet; 2008 Sep; 40(9):1062-4. PubMed ID: 19165919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.
    Fan Y; Tao JH; Zhang LP; Li LH; Ye DQ
    Int J Immunogenet; 2011 Apr; 38(2):151-9. PubMed ID: 21208380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effect of polymorphisms in the promoter of TNFAIP3 (A20) in acute pancreatitis in the Han Chinese population.
    Liu Y; Dan G; Wu L; Chen G; Wu A; Zeng P; Xu W
    PLoS One; 2014; 9(7):e103104. PubMed ID: 25050625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.
    Ciccacci C; Latini A; Perricone C; Conigliaro P; Colafrancesco S; Ceccarelli F; Priori R; Conti F; Perricone R; Novelli G; Borgiani P
    J Immunol Res; 2019; 2019():6728694. PubMed ID: 31534975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
    Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
    Kim T; Bae SC; Kang C
    Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus.
    Adrianto I; Wen F; Templeton A; Wiley G; King JB; Lessard CJ; Bates JS; Hu Y; Kelly JA; Kaufman KM; Guthridge JM; Alarcón-Riquelme ME; ; Anaya JM; Bae SC; Bang SY; Boackle SA; Brown EE; Petri MA; Gallant C; Ramsey-Goldman R; Reveille JD; Vila LM; Criswell LA; Edberg JC; Freedman BI; Gregersen PK; Gilkeson GS; Jacob CO; James JA; Kamen DL; Kimberly RP; Martin J; Merrill JT; Niewold TB; Park SY; Pons-Estel BA; Scofield RH; Stevens AM; Tsao BP; Vyse TJ; Langefeld CD; Harley JB; Moser KL; Webb CF; Humphrey MB; Montgomery CG; Gaffney PM
    Nat Genet; 2011 Mar; 43(3):253-8. PubMed ID: 21336280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes.
    Boonyasrisawat W; Eberle D; Bacci S; Zhang YY; Nolan D; Gervino EV; Johnstone MT; Trischitta V; Shoelson SE; Doria A
    Diabetes; 2007 Feb; 56(2):499-505. PubMed ID: 17259397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20: linking a complex regulator of ubiquitylation to immunity and human disease.
    Ma A; Malynn BA
    Nat Rev Immunol; 2012 Nov; 12(11):774-85. PubMed ID: 23059429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
    Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
    Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
    Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
    Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polymorphisms of tumor necrosis factor-induced protein 3 gene may contribute to the susceptibility of chronic primary immune thrombocytopenia in Chinese population.
    Zhou H; Yang J; Liu L; Zhang D; Zhou K; Li H; Zhao H; Han L; Zhou J; Liu X; Song Y; Yang R
    Platelets; 2016; 27(1):26-31. PubMed ID: 25806576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Riemekasten G; Matucci-Cerinic M; Melchers I; Hachulla E; Airo P; Diot E; Hunzelmann N; Cabane J; Mouthon L; Cracowski JL; Riccieri V; Distler J; Meyer O; Kahan A; Boileau C; Allanore Y
    Ann Rheum Dis; 2010 Nov; 69(11):1958-64. PubMed ID: 20511617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.
    Altonsy MO; Sasse SK; Phang TL; Gerber AN
    J Biol Chem; 2014 Mar; 289(12):8231-9. PubMed ID: 24500711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.